These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26710614)

  • 21. A Toxin Involved in
    VanDrisse CM; Parks AR; Escalante-Semerena JC
    mBio; 2017 May; 8(3):. PubMed ID: 28559487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic resistance and OXA-type carbapenemases-encoding genes in airborne Acinetobacter baumannii isolated from burn wards.
    Gao J; Zhao X; Bao Y; Ma R; Zhou Y; Li X; Chai T; Cai Y
    Burns; 2014 Mar; 40(2):295-9. PubMed ID: 23886986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATP-Dependent Persister Formation in Escherichia coli.
    Shan Y; Brown Gandt A; Rowe SE; Deisinger JP; Conlon BP; Lewis K
    mBio; 2017 Feb; 8(1):. PubMed ID: 28174313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex.
    Lin L; Ling BD; Li XZ
    Int J Antimicrob Agents; 2009 Jan; 33(1):27-32. PubMed ID: 18790612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-persister activity of squalamine against Acinetobacter baumannii.
    Nicol M; Mlouka MAB; Berthe T; Di Martino P; Jouenne T; Brunel JM; Dé E
    Int J Antimicrob Agents; 2019 Mar; 53(3):337-342. PubMed ID: 30423343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persister eradication: lessons from the world of natural products.
    Keren I; Mulcahy LR; Lewis K
    Methods Enzymol; 2012; 517():387-406. PubMed ID: 23084949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of Toxin-Antitoxin System Toxins Suppresses Lethality Caused by the Loss of σE in Escherichia coli.
    Daimon Y; Narita S; Akiyama Y
    J Bacteriol; 2015 Jul; 197(14):2316-24. PubMed ID: 25917909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibiotic resistance of Acinetobacter baumannii strains isolated from clinical specimens in the "Marius Nasta" Pneumology Institute, Bucharest].
    Moisoiu A; Ionită M; Sârbu L; Stoica C; Grigoriu L
    Pneumologia; 2014; 63(2):109-11. PubMed ID: 25241558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of type II toxin-antitoxin systems in the opportunistic pathogen Acinetobacter baumannii.
    Jurenaite M; Markuckas A; Suziedeliene E
    J Bacteriol; 2013 Jul; 195(14):3165-72. PubMed ID: 23667234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli.
    Keren I; Shah D; Spoering A; Kaldalu N; Lewis K
    J Bacteriol; 2004 Dec; 186(24):8172-80. PubMed ID: 15576765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii.
    Yadav R; Landersdorfer CB; Nation RL; Boyce JD; Bulitta JB
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2286-98. PubMed ID: 25645842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential genes associated with survival of Acinetobacter baumannii under ciprofloxacin stress.
    Kashyap S; Sharma P; Capalash N
    Microbes Infect; 2021; 23(9-10):104844. PubMed ID: 34098109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic effect of Myrtus communis L. essential oils and conventional antibiotics against multi-drug resistant Acinetobacter baumannii wound isolates.
    Aleksic V; Mimica-Dukic N; Simin N; Nedeljkovic NS; Knezevic P
    Phytomedicine; 2014 Oct; 21(12):1666-74. PubMed ID: 25442275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro resistance development in Acinetobacter baumannii to sulbactam and cefoperazone].
    Wieczorek P; Sacha P; Ojdana D; Milewski R; Jurczak A; Kaczyńska K; Tryniszewska E
    Med Dosw Mikrobiol; 2012; 64(1):55-62. PubMed ID: 22808730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persister cells and the riddle of biofilm survival.
    Lewis K
    Biochemistry (Mosc); 2005 Feb; 70(2):267-74. PubMed ID: 15807669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medium chain unsaturated fatty acid ethyl esters inhibit persister formation of Escherichia coli via antitoxin HipB.
    Wang M; Fang K; Hong SMC; Kim I; Jang IS; Hong SH
    Appl Microbiol Biotechnol; 2018 Oct; 102(19):8511-8524. PubMed ID: 30088019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic control of persister formation in Escherichia coli.
    Amato SM; Orman MA; Brynildsen MP
    Mol Cell; 2013 May; 50(4):475-87. PubMed ID: 23665232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxin-Antitoxin Systems in Clinical Pathogens.
    Fernández-García L; Blasco L; Lopez M; Bou G; García-Contreras R; Wood T; Tomas M
    Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27447671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of RND efflux pump and global regulators in tigecycline resistance in clinical Acinetobacter baumannii isolates.
    Li H; Wang X; Zhang Y; Zhao C; Chen H; Jiang S; Zhang F; Wang H
    Future Microbiol; 2015; 10(3):337-46. PubMed ID: 25812457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.